Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)
China · Delayed Price · Currency is CNY 10.27
+0.23 (2.29%)
Jul 27, 2026, 3:00 PM CST
SHA:605077 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,006 | 4,384 | 4,385 | 5,077 | 6,931 | 6,829 | |
Market Cap Growth | -44.25% | -0.03% | -13.63% | -26.76% | 1.50% | - |
Enterprise Value | 5,168 | 6,293 | 6,033 | 5,412 | 6,272 | 5,581 |
Last Close Price | 10.04 | 14.41 | 13.73 | 15.04 | 20.64 | 19.92 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.84 | 21.89 | 16.33 | 13.67 | 21.71 | 28.85 |
Forward PE | - | 10.34 | 8.73 | - | - | - |
PS Ratio | 0.66 | 1.05 | 1.56 | 1.82 | 3.15 | 4.28 |
PB Ratio | 0.92 | 1.35 | 1.35 | 1.64 | 2.61 | 2.81 |
P/TBV Ratio | 1.15 | 1.69 | 1.69 | 2.06 | 2.90 | 2.95 |
P/OCF Ratio | 7.02 | 10.33 | 29.93 | 8.20 | 25.49 | 25.84 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.13 | 1.50 | 2.15 | 1.95 | 2.85 | 3.50 |
EV/EBITDA Ratio | 9.06 | 10.82 | 12.67 | 9.30 | 15.49 | 20.47 |
EV/EBIT Ratio | 20.18 | 21.62 | 21.94 | 13.24 | 20.95 | 29.66 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.00 | 0.96 | 0.69 | 0.74 | 0.24 | 0.06 |
Debt / EBITDA Ratio | 5.72 | 5.37 | 4.71 | 3.93 | 1.59 | 0.52 |
Net Debt / Equity Ratio | 0.65 | 0.37 | 0.38 | -0.10 | -0.29 | -0.48 |
Net Debt / EBITDA Ratio | 3.77 | 2.10 | 2.57 | -0.52 | -1.93 | -4.30 |
Net Debt / FCF Ratio | -16.67 | -20.65 | -0.95 | 4.25 | 2.92 | 12.13 |
Asset Turnover | 0.58 | 0.56 | 0.43 | 0.55 | 0.64 | 0.72 |
Inventory Turnover | 4.31 | 4.89 | 4.49 | 7.52 | 7.09 | 6.99 |
Quick Ratio | 0.77 | 1.08 | 1.08 | 3.03 | 2.38 | 3.45 |
Current Ratio | 1.39 | 1.40 | 1.54 | 3.34 | 2.78 | 3.96 |
Return on Equity (ROE) | 4.34% | 6.23% | 8.46% | 12.94% | 12.54% | 14.03% |
Return on Assets (ROA) | 2.04% | 2.42% | 2.61% | 5.07% | 5.42% | 5.30% |
Return on Invested Capital (ROIC) | 4.55% | 5.84% | 7.09% | 15.43% | 17.78% | 16.64% |
Return on Capital Employed (ROCE) | 4.60% | 5.20% | 5.20% | 7.90% | 9.50% | 7.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.70% | 4.57% | 6.12% | 7.32% | 4.61% | 3.47% |
FCF Yield | -4.28% | -1.34% | -29.26% | -1.40% | -3.86% | -1.42% |
Dividend Yield | 4.98% | 3.47% | 3.64% | 3.58% | 2.24% | 1.65% |
Payout Ratio | 180.65% | 126.54% | 73.21% | 46.60% | 35.06% | 50.84% |
Buyback Yield / Dilution | 17.96% | 19.74% | -27.25% | -0.23% | -3.09% | -28.98% |
Total Shareholder Return | 22.94% | 23.21% | -23.61% | 3.35% | -0.86% | -27.32% |